Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.

MLA

Yan, Bing-Di, et al. “Efficacy and Safety of Antigen-Specific Immunotherapy in the Treatment of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.” Current Cancer Drug Targets, vol. 19, no. 3, 2019, pp. 199–209. EBSCOhost, https://doi.org/10.2174/1568009618666180430124738.

APA

Yan, B.-D., Cong, X.-F., Zhao, S.-S., Ren, M., Liu, Z.-L., Li, Z., Chen, C., & Yang, L. (2019). Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis. Current Cancer Drug Targets, 19(3), 199–209. https://doi.org/10.2174/1568009618666180430124738

Chicago

Yan, Bing-Di, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen, and Lei Yang. 2019. “Efficacy and Safety of Antigen-Specific Immunotherapy in the Treatment of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.” Current Cancer Drug Targets 19 (3): 199–209. doi:10.2174/1568009618666180430124738.